In This Issue:

• Prendio and BioProcure Announce Strategic Growth Investment from Primus Capital

• YEAR END PROMOTION: New Prendio Clients Get 25% Off Implementation-SIGN Before 12/31!

• Introducing Su Belagadu, Prendio’s New Vice President of Product

• The 6 Prendio-Supported Companies on Endpoints’ List of 11 ‘Most Exciting Startups’

• Read About American Instrument Exchange, This Issue’s Featured Supplier
• And More!

Prendio and BioProcure Announce Strategic Growth Investment from Primus Capital

Prendio, the leading provider of cloud-based (Software-as-a-Service) eProcurement software and supplier marketplace solutions for life sciences, and sister company BioProcure, the leader in procure-to-pay support services for biotech, have today announced a significant growth equity investment from Primus Capital (“Primus”). Primus’ investment will support continued organic growth, expansion into additional life sciences markets, and further innovation and product development.

Since 2007, Prendio and BioProcure have been committed to the mission of simplifying and optimizing procurement for life science organizations, enabling them to focus on their core research and development activities. With an expansive supplier network of more than 10,000 leading suppliers, Prendio and BioProcure’s integrated procure-to-pay solutions help streamline procurement processes, enhance supplier collaboration, and deliver financial innovation and efficiency for high-growth life science companies of all stages.

“We’ve spent over 15 years helping leading biotech companies save time and money to accelerate research and development as they strive to deliver essential therapies to the world. Prendio and BioProcure are thrilled to partner with Primus to accelerate our growth and expand the mission-critical support we deliver to our clients,” said Vincent Bologna, Co-Founder and CEO of Prendio and BioProcure. “Primus’ investment, combined with their deep SaaS expertise and valuable industry experience, will allow us to further accelerate the development of our leading life science eProcurement platform and service offerings.”

Click here to read the full press release on the Prendio website.

YEAR END PROMOTION: New Prendio Clients Get 25% Off Implementation-SIGN Before 12/31!

A Message from Partner and Co-Founder Vincent Bologna: Prendio is Welcoming a Product Strategy Expert to Our Leadership Team! 

We are thrilled to share that Prendio has added a seasoned product strategy expert to our leadership team! Please join us in welcoming Su Belagodu as Prendio’s new Vice President of Product.

Su joins our team with a wealth of experience in aligning product roadmaps and executing data-driven strategies for growth. She has a proven track record in VC and PE-backed firms and a strong commitment to data-driven decision-making.  

As VP of Product for Prendio, Su is responsible for leading the Product team in defining and achieving strategic initiatives and creating the product road map for Prendio. Su will rely on analytics, user feedback, and marketing insights to inform product choices, drive iterative improvements, and achieve sustained growth. All this information informs the technical vision for the Prendio Product and Su will lead the team in producing a holistic product strategy and ensuring it is executed throughout the development cycle. 

Your feedback combined with Su’s expertise will help us align Prendio more closely with our clients' needs and add more features to enhance the time and money savings of our procure-to-pay platform. 

Before joining Prendio, Su served as Head of Advisory Services, where she drove strategy, development, and go-to-market plans for various SaaS startups and VC and PE-backed firms. Su acquired her education and degrees from the Kellogg School of Management, Boston University, and VTU India.  

She is a founding member of Sidebar, a mentoring and networking platform for senior executives, and volunteers her time with Flare Education, where she helps high school students navigate the launch of their careers in STEM.  

We're very pleased to have Su on board and we look forward to her contributions to our product strategy and overall growth.  

Warm regards, 
Vincent Bologna 

Partner and Cofounder 

Want to learn more about how Prendio can streamline and simplify your day-to-day procurement and accounts payable processes? Click to schedule your live demo now!

Supplier Spotlight on American Instrument Exchange

Prendio is proud to partner with American Instrument Exchange! Family owned and operated since 1969, American Instrument Exchange buys, refurbishes/reconditions, and resells high-quality used laboratory equipment to over 20,000 clients worldwide. Every piece of equipment from American Instrument Exchange undergoes testing before resale, ensuring that your refurbished incubator, centrifuge, biosafety cabinet, autoclave, circulator, freeze dryer, fume hood, glassware washer, refrigerator, freezer, ultralow freezer, etc. is functioning like new.  

Why spend thousands more when you can save on equipment by purchasing from American Instrument? Conserve your valuable funding. Browse the extensive selection of equipment available by typing American Instrument Exchange into the Prendio Catalog search bar. 

Now for a limited time, take an additional 20% off your entire order with American Instrument Exchange! Contact James at info@americaninstrument.com for more information.  

The 6 Prendio-Supported Companies on Endpoints’ List of 11 ‘Most Exciting Startups’ 

This fall the leaders of the eleven biotechs dubbed “2023’s most ambitious” by biotech, drug, pharma and health news network Endpoints met together in downtown Boston’s State Room for an awards gala and celebratory sit-down dinner. 

“We are on the cusp of a revolution in genetic medicine that is as exciting as anything that has happened in the history of biotech,” said Drew Armstrong, Executive Editor for Endpoints News, at the pre-event fireside chat. “What the people in this room do has the power to change not just the course of one life, but how all of us see the world.”  

Included among the Endpoints 11 are BioProcure and Prendio clients Aera Therapeutics, Chroma Medicine, Maze Therapeutics, Orbital Therapeutics, ReNAgade Therapeutics, and Seismic Therapeutic.  

Click here to learn more about the exciting science behind these six promising startups on the Prendio blog. 

New Subscriber? Catch up on previous issues of Prendio Quarterly here! 

Follow Us

Want to Know More?